Orthofix Medical Inc. (NASDAQ:OFIX) Insider Sells $82,973.00 in Stock

Orthofix Medical Inc. (NASDAQ:OFIXGet Rating) insider Kevin J. Kenny sold 4,367 shares of Orthofix Medical stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $19.00, for a total transaction of $82,973.00. Following the transaction, the insider now owns 146,307 shares in the company, valued at $2,779,833. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Orthofix Medical Stock Down 0.4 %

NASDAQ OFIX traded down $0.08 during trading on Friday, reaching $18.86. The company’s stock had a trading volume of 161,286 shares, compared to its average volume of 340,905. The stock has a market capitalization of $689.14 million, a PE ratio of -7.61 and a beta of 0.87. Orthofix Medical Inc. has a 1-year low of $13.76 and a 1-year high of $27.91. The business has a 50-day moving average price of $17.95 and a 200-day moving average price of $19.02. The company has a current ratio of 2.98, a quick ratio of 1.37 and a debt-to-equity ratio of 0.10.

Orthofix Medical (NASDAQ:OFIXGet Rating) last posted its earnings results on Monday, March 6th. The medical device company reported $0.19 EPS for the quarter, topping the consensus estimate of ($0.37) by $0.56. Orthofix Medical had a negative return on equity of 2.14% and a negative net margin of 14.40%. The business had revenue of $122.23 million during the quarter, compared to the consensus estimate of $121.90 million. During the same quarter last year, the company earned $0.27 EPS. On average, research analysts forecast that Orthofix Medical Inc. will post -2.89 earnings per share for the current fiscal year.

Institutional Trading of Orthofix Medical

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Cerity Partners LLC acquired a new position in Orthofix Medical during the first quarter worth approximately $585,000. Quantbot Technologies LP bought a new stake in Orthofix Medical during the first quarter worth $39,000. CWM LLC raised its stake in Orthofix Medical by 433.4% during the fourth quarter. CWM LLC now owns 1,947 shares of the medical device company’s stock worth $40,000 after acquiring an additional 1,582 shares in the last quarter. UBS Group AG lifted its stake in Orthofix Medical by 2,120.8% in the 3rd quarter. UBS Group AG now owns 2,776 shares of the medical device company’s stock valued at $53,000 after purchasing an additional 2,651 shares during the last quarter. Finally, KBC Group NV grew its position in Orthofix Medical by 87.1% during the 1st quarter. KBC Group NV now owns 2,879 shares of the medical device company’s stock worth $48,000 after acquiring an additional 1,340 shares during the last quarter. 98.43% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on shares of Orthofix Medical in a research report on Sunday, May 21st. They set a “buy” rating on the stock.

Orthofix Medical Company Profile

(Get Rating)

Orthofix Medical, Inc engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion.

See Also

Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.